Form 483

Arizona Nutritional Supplements LLC Form 483, 2022-07-01

FDA issued a Form 483 to Arizona Nutritional Supplements LLC on 2022-07-01 with 5 public-safe observations.

483· Form 483 issuedFoods & Cosmetics5 observations

Arizona Nutritional Supplements LLC · Chandler, United States · Issued July 1, 2022

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

1 Jul 2022
21 CFR 111.10(b)(1)

Outer garments

Cited by Gary C Pecic, Erica R Woody, Meaghan M Rabideau

1 Jul 2022
21 CFR 111.20(b)

Physical plant - space; equipment, materials

Cited by Gary C Pecic, Erica R Woody, Meaghan M Rabideau

1 Jul 2022
21 CFR 111.210(h)(2)

Master manufacturing record - sampling, tests, examinations

Cited by Gary C Pecic, Erica R Woody, Meaghan M Rabideau

1 Jul 2022
21 CFR 111.260(g)

Batch record - results; monitoring

Cited by Gary C Pecic, Erica R Woody, Meaghan M Rabideau

1 Jul 2022
21 CFR 111.65

Quality control - quality, dietary supplement

Cited by Gary C Pecic, Erica R Woody, Meaghan M Rabideau

Inspected site

ANArizona Nutritional Supplements LLCChandler, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.10(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.20(b)Cited across public-safe Form 483 observations1x
21 CFR 111.210(h)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.260(g)Cited across public-safe Form 483 observations1x
21 CFR 111.65Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere